ZD6474 (vandetanib)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ZD6474 (vandetanib), covering 2016-03-09 to 2016-08-25. Get the full timeline:
Most recent: Clinical Trial Update: ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) [Phase 2]